Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Zobair Younossi"'
Publikováno v:
Annals of Hepatology, Vol 29, Iss 4, Pp 101179- (2024)
Externí odkaz:
https://doaj.org/article/1056fefb7b0e47fe8bbba18af627ed06
Autor:
Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramon Bataller, Ulrich Beuers, Jerome Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela E. Castro Narro, Abhijit Chowdhury, Helena Cortez-Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El-Kassas, Samuel Klein, Wayne Eskridge, Jiangao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero-Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia C. Sookoian, C. Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai-Sun Wong, Stavra Xanthakos, Yusuf Yilmaz, Zobair Younossi, Ansley Hobbs, Marcela Villota-Rivas, Philip N. Newsome
Publikováno v:
Annals of Hepatology, Vol 29, Iss 1, Pp 101133- (2024)
The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient advocates were in favor of a chan
Externí odkaz:
https://doaj.org/article/f02c612b79da4aaa8837228f72393227
Autor:
Susana Angela Borges Gonzalez, Mirtha Infante Velázquez, Adrián H. Van-Nooten, Maria Stepanova, Zobair Younossi, Marlen Ivón Castellanos Fernández
Publikováno v:
Revista Habanera de Ciencias Médicas, Vol 22, Iss 2, Pp e4897-e4897 (2023)
Introducción: La calidad de vida relacionada con la salud medida a través de los “resultados reportados por pacientes”, del inglés: patient reported outcomes (PROs) permite la detección efectiva de problemas físicos y psicológicos en pacien
Externí odkaz:
https://doaj.org/article/c519a0fb98e545c59bfde6de412e0c44
Autor:
Jörn M. Schattenberg, Alina M. Allen, Helen Jarvis, Shira Zelber-Sagi, Ken Cusi, John F. Dillon, Cyrielle Caussy, Sven M. Francque, Zobair Younossi, Naim Alkhouri, Jeffrey V. Lazarus
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-5 (2023)
Schattenberg et al. outline discussions from a recent workshop on NAFLD care and advocate for a multidisciplinary approach to managing this complex and multifactorial disease. The authors highlight gaps in current models of care and make recommendati
Externí odkaz:
https://doaj.org/article/a66f9b109e24426ea7e4ade2a74fd55b
Autor:
Joana Vieira Barbosa, Scott Milligan, Andrew Frick, Jeremy Broestl, Zobair Younossi, Nezam H. Afdhal, Michelle Lai
Publikováno v:
Hepatology Communications, Vol 6, Iss 4, Pp 765-779 (2022)
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, and its prevalence continues to rise. Fibrosis‐4 index (FIB‐4) has been shown to be a prognostic marker of liver‐related outcomes in patients with NAFL
Externí odkaz:
https://doaj.org/article/554fe686a6b545b09d479fe7dd7bf71f
Autor:
Zobair Younossi, Linda Henry
Publikováno v:
European Medical Journal Hepatology, Pp 74-83 (2022)
Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions of the world and are on trajectory to become the most common liver disease at a glob
Externí odkaz:
https://doaj.org/article/9d2e68f1dd964414a6742bdddf8c7b6b
Autor:
Zobair Younossi, Priya Aggarwal, Ichhya Shrestha, João Fernandes, Pierre Johansen, Margarida Augusto, Sunita Nair
Publikováno v:
JHEP Reports, Vol 4, Iss 9, Pp 100525- (2022)
Background & Aims: Non-alcoholic steatohepatitis (NASH) is associated with increased mortality and a high clinical burden. NASH adversely impacts patients’ health-related quality of life (HRQoL), but published data on the humanistic burden of disea
Externí odkaz:
https://doaj.org/article/972ff1831bc84fd2b5519517685dfc36
Autor:
Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveiro-Barciela, Fatema Nader, Luisa Roade, Rafael Esteban, Zobair Younossi
Publikováno v:
JHEP Reports, Vol 4, Iss 9, Pp 100526- (2022)
Externí odkaz:
https://doaj.org/article/341b39cec1464e8aa23735846db24ebd
Autor:
Maria Buti, Maria Stepanova, Adriana Palom, Mar Riveiro-Barciela, Fatema Nader, Luisa Roade, Rafael Esteban, Zobair Younossi
Publikováno v:
JHEP Reports, Vol 3, Iss 3, Pp 100280- (2021)
Background & Aims: Health-related quality of life (HRQoL) determined by patient-reported outcomes (PROs) is impaired in chronic hepatitis B (CHB) and C patients, but there are no data regarding patients with chronic hepatitis D (CHD). The aim of this
Externí odkaz:
https://doaj.org/article/c5867719915c497d8b09d0bcbd1830da
Autor:
Zobair Younossi, Katrin Kochems, Marc de Ridder, Desmond Curran, Eveline M. Bunge, Laurence de Moerlooze
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 11, Pp 2695-2706 (2017)
Despite the burden of diabetes mellitus (DM), little is known about the role of this and other metabolic syndromes on the severity of hepatitis B virus (HBV) chronicity and liver disease progression. The value of hepatitis B vaccination and its impac
Externí odkaz:
https://doaj.org/article/126a0134c80c43bd90695629fa38d4e3